ENFN - Enfusion, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD

Enfusion, Inc.

125 South Clark Street
Suite 750
Chicago, IL 60603
United States
312 253 9800

Full Time Employees1,006

Key Executives

NameTitlePayExercisedYear Born
Mr. Oleg MovchanCEO & Director876.34kN/A1975
Mr. Bradley HerringChief Financial Officer267.05kN/A1971
Ms. Bronwen BastoneChief People Officer566.25kN/A1973
Mr. Stephen MalherbeManaging PartnerN/AN/AN/A
Mr. Michael BerryChief Operating OfficerN/AN/AN/A
Mr. Daniel GromanChief Technology OfficerN/AN/A1989
Mr. Ignatius Tochukwu NjokuHead of Investor RelationsN/AN/AN/A
Matt CampobassoGen. CounselN/AN/AN/A
Mr. Dan JacobsGlobal Head of SalesN/AN/AN/A
Mr. Kabir KohliMD of Managed Services Solutioning & Global Head of Client ServicesN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. The company was founded in 1997 and is headquartered in Chicago, Illinois.

Corporate Governance

Enfusion, Inc.’s ISS Governance QualityScore as of June 1, 2023 is 9. The pillar scores are Audit: 8; Board: 9; Shareholder Rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.